As President Trump pounds the nail of MAGA resentment and envy into elite research universities, Americans best hope that ...

The uncertainty caused by US president Donald Trump’s tariffs, and cuts to US international aid, have prompted Trinity ...

• Circadian Metabolism: Nightshift workers show 58% higher obesity rates (WHO) ...

Trinity Biotech plc (Nasdaq: TRIB) a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics, including wearable ...

DUBLIN, May 15, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics, including wearable ...

Lipid receptor SR-B1 identified as a potential immunotherapy target to boost NK cell antitumor response in advanced ovarian cancer.

Shares of TRIB opened at $0.78 on Thursday. Trinity Biotech has a 12 month low of $0.48 and a 12 month high of $3.55. The firm’s 50 day moving average is $0.65 and its 200-day moving average is ...

Trinity Biotech plc acquires, together with its subsidiaries, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC ...

DUBLIN and PORTLAND, Ore., March 13, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management ...

TRINITY BIOTECH PLC - 6-K, Report of foreign issuer 21.03. Trinity Biotech files to sell 4.29M American Depositary Shares for holders 14.03. Trinity Biotech receives Nasdaq non-compliance notice ...

DUBLIN, Ireland, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions ...

Trinity Biotech plc DUBLIN, Ireland, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes ...